Toyobo Co., Ltd. (TSE: 3101), the Osaka-based diversified chemicals and materials company whose portfolio spans films and functional polymers, life science and biotech, environmental and functional materials, and a legacy textiles business, posted a sharp profit recovery for FY2026 (April 2025 – March 2026) on May 12, 2026. Consolidated revenue was essentially flat at ¥421,563 million (-0.1% from ¥422,032 million), but earnings rebounded dramatically across every line. Operating profit jumped 67.6% to ¥27,906 million, ordinary profit more than doubled — up 116.0% to ¥22,878 million — and profit attributable to owners of the parent surged 457.8% to ¥11,174 million, from just ¥2,003 million a year earlier. Earnings per share rose to ¥126.65 from ¥22.73, while return on equity recovered to 5.5% from 1.0%.
Profit recovery led by materials mix and cost cuts
The disconnect between flat revenue and a near-sixfold jump in net profit underscores that the FY2026 story was about margins, not volume. Toyobo has been steadily reshaping its portfolio away from lower-margin commodity products toward higher-value functional materials — films, functional polymers, and life-science and biotech offerings — while executing structural cost reforms across manufacturing and overhead. The result was a substantial widening of the operating margin, which climbed to roughly 6.6% from about 3.9% the prior year. The leverage was even more pronounced below the operating line: ordinary profit benefited from improved non-operating items, and the bottom line was amplified by a far lower drag from one-off and extraordinary charges than in FY2025, lifting net profit attributable to owners more than fivefold. Comprehensive income rose 367.4% to ¥25,362 million, reflecting both the earnings rebound and favourable valuation movements.
Balance sheet strengthens; operating cash flow improves
Total consolidated assets expanded to ¥627,667 million from ¥617,799 million a year earlier, while net assets rose to ¥251,995 million from ¥232,044 million on the back of retained earnings growth and the improvement in comprehensive income. The equity ratio strengthened to 34.0% from 31.6%, and net assets per share reached ¥2,417.30. Cash generation improved markedly: operating cash flow rose to ¥45,032 million from ¥30,118 million, comfortably funding investing outflows of -¥27,077 million and financing outflows of -¥16,506 million. Period-end cash and equivalents stood at ¥30,128 million, leaving the company with a healthier capital structure as it continues its portfolio transition.
Dividend held at ¥40; FY2027 guidance withheld
Toyobo declared a full-year dividend of ¥40 per share for FY2026 (no interim dividend; ¥40 paid at year-end), equivalent to a payout ratio of 31.6% on consolidated net profit. Notably, the company did not provide earnings guidance for FY2027 (ending March 2027), stating that it cannot yet reasonably estimate full-year results and will disclose forecasts once they become estimable. The FY2027 dividend is likewise undecided. Investors will therefore need to wait for a subsequent disclosure before the company commits to FY2027 revenue, profit, or distribution targets — a posture that reflects ongoing uncertainty over input costs, demand, and the pace of its materials-portfolio shift.
| Metric | FY2026 | FY2025 | YoY |
|---|---|---|---|
| Revenue (¥ million) | 421,563 | 422,032 | −0.1% |
| Operating profit (¥ million) | 27,906 | 16,653 | +67.6% |
| Ordinary profit (¥ million) | 22,878 | 10,591 | +116.0% |
| Net profit attrib. to owners (¥ million) | 11,174 | 2,003 | +457.8% |
| EPS (¥) | 126.65 | 22.73 | +457.2% |
| ROE | 5.5% | 1.0% | +4.5pp |
| Total assets (¥ million) | 627,667 | 617,799 | +1.6% |
| Equity ratio | 34.0% | 31.6% | +2.4pp |
| Operating cash flow (¥ million) | 45,032 | 30,118 | +49.5% |
| Annual dividend (¥) | 40 | 40 | ±0.0% |
| FY2027 guidance | Not disclosed | — | — |
JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.